Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Annals of the American Thoracic Society|July 10, 2020
Clinical Effectiveness of Lumacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for F508del-CFTR. A Clinical TrialScott D Sagel, Umer Khan, Sonya L Heltshe, et al.Pediatric Pulmonology|February 3, 2015
Novel outcome measures for clinical trials in cystic fibrosisHarm A W M Tiddens, Michael Puderbach, Jose G Venegas, et al.Plos One|February 22, 2014
A biophysical basis for mucus solids concentration as a candidate biomarker for airways diseaseDavid B Hill, Paula A Vasquez, John Mellnik, et al.American Journal of Respiratory and Critical Care Medicine|June 14, 2014
Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosisSteven M Rowe, Sonya L Heltshe, Tanja Gonska, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 18, 2017
Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTRScott H Donaldson, George M Solomon, Pamela L Zeitlin, et al.Journal of Clinical Microbiology|November 12, 2010
Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centersFranziska A Stressmann, Geraint B Rogers, Erich R Klem, et al.JCI Insight|December 20, 2019
Dynamic perfluorinated gas MRI reveals abnormal ventilation despite normal FEV1 in cystic fibrosisJennifer L Goralski, Sang Hun Chung, Tyler M Glass, et al.The Journal of Clinical Investigation|June 4, 2014
Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressureAshley G Henderson, Camille Ehre, Brian Button, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 4, 2021
Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-studyScott H Donaldson, Beth L Laube, Peter Mogayzel, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 14, 2024
The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC StudyScott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, et al.Pageof 7